It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
This piece explains how wash sale rules affect Dividend Etf losses, with practical strategies to stay compliant and preserve tax benefits.
20,231 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Oil stocks COP and Diamondback Energy offer very different risk-and-reward profiles. This guide breaks down cash flow...
A sharp pullback in Home Depot shares has traders debating whether now is the moment to buy. This guide breaks down t...
Investors eyeing $12,000 a month in passive income are rethinking portfolio size as yields rise. This piece lays out ...
As AI and data demand surge, investors eye NuScale Power and the small modular reactor trend. Can nuscale power next ...
Income-focused investors are turning to a small group of high-yield energy names that offer cash-flow visibility and ...
Costco posted solid June numbers, with a 10.6% rise in sales and a strong e-commerce lift. Yet the stock declined, si...
Tariff news rattled markets, but crypto found footing and moved higher. This piece breaks down the rebound dynamics, ...
A middle-aged couple with a sizable traditional retirement balance confronts a looming tax spike as required withdraw...
SpaceX shocked markets with a rapid price swing after its public debut. This guide breaks down how to evaluate the di...
Gas-price swings touch every part of the economy and your portfolio. This guide breaks down what's driving those move...
EWZ’s semi-annual payouts are highly dependent on Petrobras and Vale, delivering big checks in buoyant commodity mark...